Michael D. Geschwind
Psychiatry and Mental health · 2013–2018
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Psychiatry and Mental health — 50 citations into it
- Physiology — 41 citations into it
- Pharmacology — 6 citations into it
Whom Michael D. Geschwind trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Michael D. Geschwind's perspective
Ordered by how strongly the researchers Michael D. Geschwind trusts endorse each paper. Same corpus, a different order for every researcher.
- Neuropathological stageing of Alzheimer-related changes
- Criteria for the diagnosis of corticobasal degeneration (Neurology)
- Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. (Archives of Neurology)
- Classification of primary progressive aphasia and its variants (Neurology)
- Tau PET imaging in aging and early Alzheimer’s disease (Annals of Neurology)
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia (Journal of the American Medical Association (JAMA))
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. (Lancet Neurology)
- Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study (Lancet Neurology)
- CSF markers for incipient Alzheimer's disease. (Lancet Neurology)
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B (Annals of Neurology)
Their papers
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. (2018) — 916 citations
- A clinical approach to diagnosis of autoimmune encephalitis (2016) — 3,526 citations
- Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease (2013) — 676 citations